Crinetics Pharmaceuticals EPS - Earnings per Share 2017-2024 | CRNX

Crinetics Pharmaceuticals earnings per share (EPS) for the twelve months ending September 30, 2024 was $-3.72, a 2.48% increase year-over-year.

  • Crinetics Pharmaceuticals EPS for the quarter ending September 30, 2024 was $-0.96, a 4.95% decline year-over-year.
  • Crinetics Pharmaceuticals 2023 annual EPS was $-3.69, a 17.14% increase from 2022.
  • Crinetics Pharmaceuticals 2022 annual EPS was $-3.15, a 12.5% increase from 2021.
  • Crinetics Pharmaceuticals 2021 annual EPS was $-2.8, a 15.7% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Crinetics Pharmaceuticals EPS - Earnings per Share 2017-2024 | CRNX

  • Crinetics Pharmaceuticals EPS for the quarter ending September 30, 2024 was $-0.96, a 4.95% decline year-over-year.
  • Crinetics Pharmaceuticals 2023 annual EPS was $-3.69, a 17.14% increase from 2022.
  • Crinetics Pharmaceuticals 2022 annual EPS was $-3.15, a 12.5% increase from 2021.
  • Crinetics Pharmaceuticals 2021 annual EPS was $-2.8, a 15.7% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.